Multiple Sclerosis News Today Forums Forums Trials and Research What’s hot and what’s not among MS therapies?

  • What’s hot and what’s not among MS therapies?

    Posted by MS News Today Moderator on April 21, 2018 at 7:17 am

    The new kids on the MS block, disease-modifying therapies (DMT) such as Genentech’s Ocrevus (ocrelizumab) and Sanofi Genzyme’s Lemtrada (alemtuzumab), are attracting a lot of interest these days. But, some DMTs that have been around for more than two decades are still being prescribed by a lot of neurologists.

    Read more about “What’s Hot and What’s Not Among MS Therapies?”.

    What do you know about these therapies? Which ones have you already tried? Did they work?

    replied 6 years, 1 month ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.